title: Low density Lipoprotein cholesterol target: Changing goal posts.
abstract: Elevated low density lipoprotein cholesterol (LDL) has been identified as one of the strongest correctable risk factors for cardiovascular disease in patients with diabetes. The reduction in cardiovascular events with pharmacological therapy aimed at LDL lowering is well documented in both primary prevention and secondary prevention. In this article, we review the evolving trend of aggressive LDL cholesterol lowering strategies.
authors.affiliation: Department of Endocrinology, St. Johns Medical College Hospital, Bangalore - 560 034, Karnataka, India.
authors.forename: Ganapathi
authors.initials: G
authors.lastname: Bantwal
authors.forename: Belinda
authors.initials: B
authors.lastname: George
keywords: LDL; cardiovascular disease; diabetes
references.citation: Circulation. 2002 Dec 17;106(25):3143-421
references.pmid: 12485966
references.citation: J Am Coll Cardiol. 2004 Jun 2;43(11):2142-6
references.pmid: 15172426
references.citation: Atherosclerosis. 2011 Jul;217(1):3-46
references.pmid: 21882396
references.citation: Diabetes Care. 2006 Jun;29(6):1220-6
references.pmid: 16731999
references.citation: JAMA. 2005 Nov 16;294(19):2437-45
references.pmid: 16287954
references.citation: Diabetes Care. 2008 Apr;31(4):811-22
references.pmid: 18375431
references.citation: Diabetes Care. 2012 Jan;35 Suppl 1:S11-63
references.pmid: 22187469
references.citation: N Engl J Med. 2004 Apr 8;350(15):1495-504
references.pmid: 15007110